Friday, June 24, 2022 7:45:31 PM
I'm of the belief that the SEC, FDA, etc. insist on far too much of what's essentially CYA language in all sorts of ways on things that should be apparent to investors, likewise it's Doctors who need to see the cautions on using prescription drugs, not the patients watching a TV commercial that spends more time on negative side effects that are possible than benefits.
I believe that NWBO is less risky than most biotech's which don't have approved products based on the trial results we've seen, I think it will get even better as we get the additional information that should be contained in the Journal that explains how the median for the Top 100 is now in excess of 7 years, as Dr. Ashkan previously indicated.
Nothing is absolutely certain, weeks ago we learned of a friend who was found to have pancreatic cancer, we know it's a terrible disease, but we thought she'd have a couple years, as others we knew with the disease. We just learned that she passed away today. I suppose it's a blessing not to go through the years of pain and suffering, but no one wants to say goodbye that quickly. Those I knew who spent years with pancreatic cancer, including my 94 year old grandmother, did have some good time after their diagnosis, in spite of all the pain. We all need to take our blessings while we can.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM